January 27, 2014
Sanwa Kagaku Kenkyusho announced on January 22 that it has concluded a licensing agreement with Dong-A ST of South Korea for the development and commercialization in Japan of biosimilar darbepoetin alfa (original product: Nesp), a treatment for renal anemia. Sanwa...read more